Sunrise Pharmaceutical, Inc., filed suit against Leason Ellis client Vision Pharma, LLC alleging unfair competition and false advertising under the Lanham Act, unfair competition under state statutory and common law, tortious interference with prospective economic relations, and trade libel. The District Court dismissed Sunrise’s complaint, holding that the Noerr-Pennington doctrine barred Sunrise’s claims. We defended the appeal of the district court’s decision and the Third Circuit Court of Appeals affirmed the District Court’s order that Sunrise failed to plausibly plead a right to relief. Petition for rehearing was denied.
The Leason Ellis team included partner Cameron Reuber and associate Henry Gabathuler who argued the Third Circuit appeal. See Sunrise Pharmaceutical, Inc. v. Vision Pharma, LLC, et al., 19-1960 (3d. Cir); Sunrise Pharmaceutical, Inc. v. Vision Pharma, LLC, et al., Case 2:17-cv-04074 (D. NJ).
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.